PlainRecalls
FDA Devices Moderate Class II Terminated

Ultra2 Resolution Variants System for Abnormal Hemoglobin Quantitation

Reported: November 11, 2020 Initiated: October 9, 2020 #Z-0321-2021

Product Description

Ultra2 Resolution Variants System for Abnormal Hemoglobin Quantitation

Reason for Recall

The product did not receive pre-market approval or clearance.

Details

Recalling Firm
Primus Corporation
Units Affected
97 devices (USA only)
Distribution
US - Arizona, California, District of Columbia, Florida, Georgia, Illinois, Louisiana, Massachusetts, Michigan, Missouri, Nebraska, New Jersey, Nevada, New York, Pennsylvania, Rhode Island, Tennessee, Texas, Virginia, Wisconsin OUS - Bahrain, Iran, Malaysia, Saudi Arabia, Taiwan, Turkey, UAE, UK, Vietnam
Location
Kansas City, MO

Frequently Asked Questions

What product was recalled?
Ultra2 Resolution Variants System for Abnormal Hemoglobin Quantitation. Recalled by Primus Corporation. Units affected: 97 devices (USA only).
Why was this product recalled?
The product did not receive pre-market approval or clearance.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 11, 2020. Severity: Moderate. Recall number: Z-0321-2021.